Back to top
more

DexCom (DXCM)

(Delayed Data from NSDQ)

$65.68 USD

65.68
3,456,884

-1.42 (-2.12%)

Updated Oct 3, 2024 04:00 PM ET

After-Market: $65.69 +0.01 (0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 23% (59 out of 252)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

DexCom (DXCM) to Report Q4 Earnings: What's in the Cards?

DexCom's (DXCM) fourth-quarter results are likely to reflect rising global awareness of its real-time CGM.

Is SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?

Smart Beta ETF report for XHE

DexCom (DXCM) Gains But Lags Market: What You Should Know

DexCom (DXCM) closed the most recent trading day at $108.03, moving +0.3% from the previous trading session.

Should iShares Russell Mid-Cap Growth ETF (IWP) Be on Your Investing Radar?

Style Box ETF report for IWP

DexCom (DXCM) Gains But Lags Market: What You Should Know

DexCom (DXCM) closed the most recent trading day at $106.72, moving +0.07% from the previous trading session.

Masimo's (MASI) Patient Monitoring Devices Favored by New Study

Masimo's (MASI) patient monitoring devices continue to aid researchers in their assessment of different ventilatory strategies for brain oxygenation during thoracoscopic surgery.

DexCom (DXCM) Gains But Lags Market: What You Should Know

DexCom (DXCM) closed the most recent trading day at $107.86, moving +1.56% from the previous trading session.

Should Vanguard MidCap Growth ETF (VOT) Be on Your Investing Radar?

Style Box ETF report for VOT

DexCom (DXCM) Outpaces Stock Market Gains: What You Should Know

DexCom (DXCM) closed at $107.14 in the latest trading session, marking a +0.92% move from the prior day.

DexCom (DXCM) Announces Solid Preliminary Q4 Revenues

DexCom's (DXCM) revenue growth in the fourth quarter is likely to have been boosted by continued strength in its CGM sales.

3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio (Revised)

Investors continue to be optimistic about DexCom (DXCM) owing to its strong product portfolio.

3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio

Investors continue to be optimistic about DexCom (DXCM) owing to its strong product portfolio.

DexCom (DXCM) Gains As Market Dips: What You Should Know

In the latest trading session, DexCom (DXCM) closed at $113.24, marking a +1.04% move from the previous day.

DexCom (DXCM) Stock Moves -0.1%: What You Should Know

DexCom (DXCM) closed at $109.77 in the latest trading session, marking a -0.1% move from the prior day.

DexCom (DXCM) Stock Moves -0.94%: What You Should Know

DexCom (DXCM) closed the most recent trading day at $113.68, moving -0.94% from the previous trading session.

DexCom (DXCM) Dips More Than Broader Markets: What You Should Know

In the latest trading session, DexCom (DXCM) closed at $114.63, marking a -1.39% move from the previous day.

3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio

Investors continue to be optimistic about DexCom (DXCM) owing to its strong product portfolio.

Mark Vickery headshot

Top Research Reports for Walmart, Toyota Motor & Schlumberger

Today's Research Daily features new research reports on 16 major stocks, including Walmart Inc. (WMT), Toyota Motor Corporation (TM) and Schlumberger Limited (SLB).

Benjamin Rains headshot

3 Stocks to Buy for Long-Term Growth Upside

Investors might want to consider buying stocks after the strong first half of the fourth quarter. Today, we explore three stocks that are set to expand within three crucial growth industries.

3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio

Investors continue to be optimistic about DexCom (DXCM) owing to its strong product portfolio.

DexCom (DXCM) Q3 Earnings Beat Estimates, Guidance Revised

DexCom's (DXCM) third-quarter results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Monitoring system.

DexCom (DXCM) Q3 Earnings and Revenues Surpass Estimates

DexCom (DXCM) delivered earnings and revenue surprises of 16.67% and 2.25%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Indrajit Bandyopadhyay headshot

Medical Device Stocks' Q3 Earnings on Oct 27: LH, BIO & More

Medical Device players are likely to have benefited from the reopening of economies and several efforts to combat staffing challenges. Let's see how LH, BIO, BAX, DXCM and WST are likely to fare this time.

Should You Buy Dexcom (DXCM) Ahead of Earnings?

Dexcom (DXCM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.